Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy?

Diabetic Medicine

Volumn 15, Issue 11, 1998, Pages 946-952

  Holmes Walker, D J ^a   Mitchell, P ^b   Boyages, S C ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Diabetic retinopathy; Maternally inherited diabetes and deafness; Mitochondrial DNA; Pigmentary retinopathy

Indexed keywords

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; MALE; PREVALENCE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DEAFNESS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DNA, MITOCHONDRIAL; ERYTHROCYTES; GENOMIC IMPRINTING; GLYCOLYSIS; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; POINT MUTATION; REFERENCE VALUES; RNA, TRANSFER, LEU; SORBITOL;

EID: 0031742026     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(1998110)15:11<946::AID-DIA707>3.0.CO;2-L     Document Type: Article

References (27)

1. leu(UUR) gene. Diabetes Care 1995; 18: 1023-1028.
2. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath R. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992; 340: 1376-1379.
3. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-968.
4. Maassen J, Kadowaki T. Maternally inherited diabetes mellitus and deafness. A new diabetes subtype. Diabetologia 1996; 39: 375-382.
5. Newkirk JE, Taylor RW, Howell N, Bindoff LA, Chinnery PF, Alberti KGMM, et al. Maternal inheritance diabetes and deafness: prevalence in a hospital diabetic population. Diabetic Med 1997; 14: 457-460.
6. Mullie MA, Harding AE, Petty RKH, Ikeda H, Morgan-Hughes JA, Sanders MD. The retinal manifestations of mitochondrial myopathy. Arch Ophthalmol 1985; 103: 1825-1830.
7. leu(UUR) gene mutation in Japanese patients. Diabetologia 1994; 37: 504-510.
8. leu(UUR) gene: a study in seven families with mitochondrial encephalomyopathy and stroke-like episodes (MELAS). Diabetologia 1994; 37: 818-825.
9. leu(UUR) gene. Diabetologia 1995; 38: 193-200.
10. Malone JI, Leavengood H, Peterson MJ, O'Brien MM, Page G, Aldinger CE. Red blood cell sorbitol as an indicator of polyol pathway activity. Inhibition by sorbinil in insulin-dependent diabetic subjects. Diabetes 1984; 33: 45-49
11. Malone JI, Knox G, Benford S, Tedesco TA. Red blood cell sorbitol: an indicator of diabetic control. Diabetes 1980; 29: 861-864.
12. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256: 628-632.
13. Sue CM, Holmes-Walker DJ, Morris JGL, Boyages SC, Crimmens DS, Byrne E. Mitochondrial gene mutations and diabetes mellitus (letter). Lancet 1993; 341: 437-438.
14. Sue CM, Mitchell P, Moshegov C, Crimmens DS, Byrne E, Morris JGL. Pigmentary retinopathy associated with the mitochondrial DNA 3243 point mutation. Neurology 1997; 49: 1013-1017.
15. Kotsimbos N, Jean-Francois MJB, Huizing M, Kapsa R, Lertrit P, Siregar NC, et al. Rapid and noninvasive screening of patients with mitochondrial myopathy. Human Mutation 1994; 4: 132-135.
16. Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Arch Opthalmol 1958; 60: 280-289.
17. Klein R, Klein BE, Magli YL, Brothers RJ, Meuer SM, Moss SE, Davis MD. An alternative method of grading diabetic retinopathy. Ophthalmology 1986; 93: 1183-1187.
18. Mitchell P, Moffitt P. Update and implications from the Newcastle diabetic retinopathy study. Aust NZ J Ophthalmol 1990; 18: 13-17.
19. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy III: Prevalence and risk of diabetic retinopathy when age is thirty or more years. Arch ophthalmol 1984; 102: 527-532.
20. Engerman RL, Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 1984; 33: 97-100.
21. Van den Enden MK, Nyengaard JR, Ostrow E, Burgan JH, Williamson JR. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 1995; 36: 1675-1685.
22. McCabe ERB. Microcompartmentation of energy metabolism at the outer mitochondrial membrane. J Bioenergetics and Biomembranes 1994; 26: 317-325.
23. Jensen VA, Lundbaek K. Diabetic pigmentopathy of the macula lutea. A new ophthalmological anomaly in longterm diabetes. Ophthalmologica 1995; 129: 89-93.
24. Algvere P, Efendic S, Luft R, Wajngot A. Retinal microangiopathy and pigment epithelial lesions in subjects with normal, borderline and decreased oral glucose tolerance. Br J Ophthalmol 1985; 69: 416-419.
25. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995; 333: 638-644.
26. Chang TS, Johns DR, Walker D, de la Cruz Z, Maumenee IH, Green WR. Ocular clinicopathological study of the mitochondrial encephalomyopathy overlap syndromes. Arch Ophthalmol 1993; 111: 1254-1262.
27. Ciuchi E, Odetti P, Prando R. Relationship between glutathione and sorbitol concentrations in erythrocytes from diabetic patients. Metabolism 1996; 45: 611-613.